Date of management change: April 30, 2024
South San Francisco, California-based Akero Therapeutics Appointed Scott Gangloff as Chief Technology Officer
Akero Therapeutics is developing best-in-class medicines that restore metabolic balance to treat non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases.
Scott Gangloff is Chief Technology Officer at Akero Therapeutics. Previously, Scott held various senior IT leadership roles in the industry.
News
Short ProfileName: Scott Gangloff
Title: Chief Technology Officer
Company: Akero Therapeutics
Industry: Biotechnology
Current Contact InfoEmail: *****@akerotx.com
Phone:.***.***.*48*
To get full contact details, please sign in or
Other IT executives who recently changed jobs as well: Romanossian Raffi, Hendricks Carl, Videmsek Mike, Kondrak Mark, Luttrell David, Needham Jeffrey, Allison Tyler, Zobrist Brad, Perelman Rubin, Carte Shawn, Ross Scott
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.
